Viruses versus Humans

19/04/2026

TWiV 1314: Clinical update with Dr. Daniel Griffin 🩺 Dr. Griffin and Vincent Racaniello are dismayed but not surprised by poll results suggesting most Americans doubt vaccine safety, that the head of the CDC and NIH delayed release of a report on the safety of the COVID-19 vaccine, how Nature works to spread disease without the help of the lab, and the about face of the Trump administration to nominate a pro-vaccine candidate for CDC director. Then Dr. Griffin deep dives into the measles outbreak, how the influenza vaccine may attenuate stroke and acute cardiac disease following virus infection, how to access and pay for Paxlovid, and contacting your federal government representative to stop the assault on science and biomedical research. 📺 bit.ly/4cSoRkU

15/04/2026

Now out: "When psychologizing causes harm", a joint statement by patients, clinicians and researchers 👇👇

We read with attention the article by Ranque and Cogan (1) entitled "Internal medicine at the crossroads of Long COVID diagnosis and management." W...

15/04/2026

According to a new study, RSV is associated with high rates of complications and death among older adults hospitalized with the condition, and older RSV patients may have worse health outcomes than older adults hospitalized for influenza.

Read more: https://ow.ly/Cf9E50YIpwo

15/04/2026

De novo recovery of Ghana virus, an African bat Henipavirus, reveals differential tropism and attenuated pathogenicity compared to Nipah virus

http://dlvr.it/TRzMZm

15/04/2026

TWiV 1312: Clinical update with Dr. Daniel Griffin 🩺 Dr. Griffin and Vincent Racaniello are aghast at the CDC’s decision to no longer test for rabies and mpox and the revised charter for its advisory committee on immunization practices. Then Dr. Griffin deep dives into the measles outbreak, PEMGARDA authorized use for certain immunocompromised individuals, how to access and pay for Paxlovid, if the nasal microbiome modulates COVID-19 disease severity, and contacting your federal government representative to stop the assault on science and biomedical research. 📺 bit.ly/4spVJpK

15/04/2026

Dr. Jean Paul Carrera (GVN; Gorgas Memorial Institute for Health Studies) presented “Emergence And Spread Of Oropouche Virus In The Darién Gap, Panama” during the Arboviral Threats session at on March 5, 2026.

He examined the emergence and spread of Oropouche virus in the Darién Gap, highlighting the role of field-based surveillance in understanding and responding to emerging arboviral threats.

Read the release: https://gvn.org/global-virus-network-annual-meeting-advances-a-science-driven-agenda-for-pandemic-preparedness/

13/04/2026

Dr. Eduardo Gotuzzo (GVN Center of Excellence Director; Universidad Peruana Cayetano Heredia), spoke during the Oncogenesis and Retroviruses panel at the on March 4, 2026.

He highlighted key risk factors for HTLV-associated malignancies, including early-life infection, high proviral load, severe co-infections, and family history.

Gotuzzo emphasized the importance of identifying which infected individuals are most likely to progress to malignancy so clinicians can better monitor disease risk and improve long-term outcomes.

Read the release: https://ow.ly/Yc0m50YGux6

13/04/2026

TWiV 1313: Maybe they’re all dementia vaccines 〰️ TWiV reviews evidence that influenza standard and high-dose vaccines reduce risk of Alzheimer’s dementia, and spread of deltaviruses by a viral Trojan horse mechanism. Hosts: Vincent Racaniello, Alan Dove, and Rich Condit. 📺 bit.ly/3Q4azou

11/04/2026

Virology Lectures 2026 #19: Vaccines 〰️ Vaccines prevent acute and chronic disease, and they save lives. In this lecture we discuss examples of different types of vaccines, including inactivated vaccines, subunit vaccines, and replication competent, infectious vaccines. These concepts are illustrated using vaccines for poliovirus, influenza virus, hepatitis B virus, varicella-zoster virus, and human papillomavirus. 📺 bit.ly/4voznHO

11/04/2026

Dr. Peter Palese (GVN Center of Excellence Director; Icahn School of Medicine at Mount Sinai) presented “A Universal Influenza Virus Vaccine Based on Chimeric Hemagglutinins” during the Influenza & RSV: Obvious Hazards for the Future session at on March 5, 2026.

He discussed the development of a universal influenza vaccine targeting conserved regions of the virus through chimeric hemagglutinin constructs, enabling broader and more durable protection across multiple strains and reducing reliance on annually updated vaccines.

Read the release: https://ow.ly/fZ0Q50YGL5L

11/04/2026

Researchers keep discovering more about the long-term neurological effects of SARS-CoV-2.

16/03/2026

TWiV 1305: Lab leak idea called on the carpet 🐍 TWiV introduces sunshine virus of carpet pythons and its effect after experimental infection, and development of a new tool to distinguish between naturally occurring outbreaks and those that arise from lab accidents. Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Brianne Barker. 📺 bit.ly/3NEfZpi